Opzelura

ruxolitinib · Incyte Corporation

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Opzelura, covering 2021-09-21 to 2026-08-03. Get the full timeline:

Most recent: EMA Authorised: Opzelura (ruxolitinib phosphate) — Incyte Biosciences Distribution B.V.